Active Ingredient (In Each Caplet)
CHLORPHENIRAMINE MALEATE 2.0 mg
PHENYLEPHRINE HYDROCHLORIDE 5.0 mg
ACETAMINOPHEN 500 mg
The following Structured Product Label (SPL) was submitted to the FDA by Salimex, S.a. for the product Desenfriol-d (NDC 53666-417). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each caplet), purpose, uses, warnings, do not use, ask a doctor before use if you have, ask a doctor or pharmacist before use if you are, when using this product, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
CHLORPHENIRAMINE MALEATE 2.0 mg
PHENYLEPHRINE HYDROCHLORIDE 5.0 mg
ACETAMINOPHEN 500 mg
Pain reliever
Antihistamine
Nasal decongestant
These could be signs of a serious condition.otc
ask a health professional before use.
Overdose warning: In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222). Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
do not take more than directed (see overdose warning)
adults and children 12 years and over
children under 12 years
anhydrous citric acid, carboxymethylcellulose sodium, D&C red #33, FD&C blue #1, FD&C red 40, flavors, glycerin, microrocrystalline cellulose, purified water, sodium benzoate, sorbitol, sucrose, xanthan gum
* Please review the disclaimer below.